Euglena Co., Ltd. (2931.T)
JPY 399.0
(0.76%)
JPY 399.0
(0.76%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | 676 Million JPY | 130.25% |
| 2021 | -2.23 Billion JPY | -211.67% |
| 2020 | -717.05 Million JPY | 88.26% |
| 2019 | -6.1 Billion JPY | -1780.61% |
| 2018 | -324.71 Million JPY | -119.41% |
| 2017 | 1.67 Billion JPY | 32.02% |
| 2016 | 1.26 Billion JPY | 42.34% |
| 2015 | 890.07 Million JPY | 241.49% |
| 2014 | 260.64 Million JPY | -13.8% |
| 2013 | 302.36 Million JPY | -5.81% |
| 2012 | 321.02 Million JPY | 8.59% |
| 2011 | 295.62 Million JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q1 | 10 Million JPY | 100.88% |
| 2023 Q3 | -39 Million JPY | 90.46% |
| 2023 Q2 | -409 Million JPY | -4190.0% |
| 2022 Q2 | -593 Million JPY | -4053.33% |
| 2022 FY | - JPY | 130.25% |
| 2022 Q4 | -1.13 Billion JPY | -44.4% |
| 2022 Q3 | -786 Million JPY | -32.55% |
| 2022 Q1 | 15 Million JPY | 0.0% |
| 2021 Q2 | -450.57 Million JPY | -311.87% |
| 2021 Q3 | -3.07 Billion JPY | -583.4% |
| 2021 Q1 | 212.66 Million JPY | 165.38% |
| 2021 FY | - JPY | -211.67% |
| 2020 Q3 | -634.84 Million JPY | 6.96% |
| 2020 Q2 | -682.35 Million JPY | -822.01% |
| 2020 FY | - JPY | 88.26% |
| 2020 Q4 | -325.27 Million JPY | 48.76% |
| 2020 Q1 | 94.5 Million JPY | 144.33% |
| 2019 Q1 | 68.89 Million JPY | 101.07% |
| 2019 FY | - JPY | -1780.61% |
| 2019 Q4 | -213.18 Million JPY | 70.12% |
| 2019 Q3 | -713.5 Million JPY | -286646.18% |
| 2019 Q2 | 249 Thousand JPY | -99.64% |
| 2018 Q3 | 164.77 Million JPY | 145.68% |
| 2018 Q1 | -531.07 Million JPY | -46.02% |
| 2018 FY | - JPY | -119.41% |
| 2018 Q4 | -6.41 Billion JPY | -3995.53% |
| 2018 Q2 | -360.67 Million JPY | 32.08% |
| 2017 Q1 | 143.13 Million JPY | -52.75% |
| 2017 Q4 | -363.69 Million JPY | -161.34% |
| 2017 FY | - JPY | 32.02% |
| 2017 Q3 | 592.9 Million JPY | 249.23% |
| 2017 Q2 | 169.77 Million JPY | 18.61% |
| 2016 Q1 | 468.4 Million JPY | 517.3% |
| 2016 FY | - JPY | 42.34% |
| 2016 Q4 | 302.92 Million JPY | 505.14% |
| 2016 Q3 | -74.77 Million JPY | -115.66% |
| 2016 Q2 | 477.35 Million JPY | 1.91% |
| 2015 Q3 | 213.27 Million JPY | 5.61% |
| 2015 Q4 | 75.87 Million JPY | -64.42% |
| 2015 FY | - JPY | 241.49% |
| 2015 Q1 | 231.26 Million JPY | 216.12% |
| 2015 Q2 | 201.94 Million JPY | -12.68% |
| 2014 Q2 | 78.1 Million JPY | 116.48% |
| 2014 Q4 | 73.15 Million JPY | 15.46% |
| 2014 Q3 | 63.36 Million JPY | -18.87% |
| 2014 Q1 | 36.07 Million JPY | 117.5% |
| 2014 FY | - JPY | -13.8% |
| 2013 Q1 | 364.18 Million JPY | 1623.55% |
| 2013 Q4 | 16.58 Million JPY | -85.9% |
| 2013 Q3 | 117.65 Million JPY | 36.51% |
| 2013 Q2 | 86.18 Million JPY | -76.33% |
| 2013 FY | - JPY | -5.81% |
| 2012 FY | - JPY | 8.59% |
| 2012 Q4 | 21.13 Million JPY | 0.0% |
| 2011 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Kitanotatsujin Corporation | 1.58 Billion JPY | 57.428% |
| BEAUTY GARAGE Inc. | 1.96 Billion JPY | 65.595% |
| Axas Holdings Co.,Ltd. | 555.75 Million JPY | -21.636% |
| C.I. Medical Co.,Ltd. | 4.01 Billion JPY | 83.155% |
| Kao Corporation | 154.49 Billion JPY | 99.562% |
| Niitaka Co., Ltd. | 1.36 Billion JPY | 50.64% |
| Rohto Pharmaceutical Co.,Ltd. | 48.85 Billion JPY | 98.616% |
| Shiseido Company, Limited | 106.46 Billion JPY | 99.365% |
| Lion Corporation | 42.31 Billion JPY | 98.402% |
| Mandom Corporation | 6.69 Billion JPY | 89.909% |
| Ivy Cosmetics Corporation | 242.6 Million JPY | -178.648% |
| Milbon Co., Ltd. | 7.8 Billion JPY | 91.334% |
| Nippon Shikizai, Inc. | 1.28 Billion JPY | 47.539% |
| Fancl Corporation | 16.6 Billion JPY | 95.928% |
| KOSÉ Corporation | 26.85 Billion JPY | 97.483% |
| Cota Co., Ltd. | 2.26 Billion JPY | 70.2% |
| HABA Laboratories,Inc. | -1.31 Billion JPY | 151.434% |
| C'bon Cosmetics Co.,Ltd. | 171.84 Million JPY | -293.373% |
| Pola Orbis Holdings Inc. | 23.17 Billion JPY | 97.083% |
| Noevir Holdings Co., Ltd. | 12.24 Billion JPY | 94.479% |
| Adjuvant Holdings Co.,Ltd. | 124 Million JPY | -445.161% |
| Almado, Inc. | 983.21 Million JPY | 31.246% |
| I-ne CO., LTD. | 4.7 Billion JPY | 85.617% |
| Premier Anti-Aging Co., Ltd. | -627 Million JPY | 207.815% |
| Liberta Co.,Ltd. | 318.19 Million JPY | -112.45% |
| AXXZIA Inc. | 1.28 Billion JPY | 47.455% |
| S.T. Corporation | 2.62 Billion JPY | 74.257% |
| Kobayashi Pharmaceutical Co., Ltd. | 31.68 Billion JPY | 97.866% |
| Earth Corporation | 10.6 Billion JPY | 93.627% |
| Sagami Rubber Industries Co., Ltd. | 1.09 Billion JPY | 38.239% |
| Asahi Eito Holdings Co.,Ltd. | -573.98 Million JPY | 217.774% |
| Ya-Man Ltd. | 1.43 Billion JPY | 52.95% |
| MTG Co., Ltd. | 4.39 Billion JPY | 84.615% |
| TRANSACTION CO.,Ltd. | 5.8 Billion JPY | 88.363% |
| SHOBIDO Corporation | 1.11 Billion JPY | 39.11% |
| Artnature Inc. | 3.78 Billion JPY | 82.149% |
| Pigeon Corporation | 15.8 Billion JPY | 95.723% |
| Unicharm Corporation | 178.01 Billion JPY | 99.62% |
| Paltac Corporation | 35.92 Billion JPY | 98.118% |
| CB GROUP MANAGEMENT Co., Ltd. | 3.28 Billion JPY | 79.422% |